Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

804 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.
Arunachalam PS, Walls AC, Golden N, Atyeo C, Fischinger S, Li C, Aye P, Navarro MJ, Lai L, Edara VV, Röltgen K, Rogers K, Shirreff L, Ferrell DE, Wrenn S, Pettie D, Kraft JC, Miranda MC, Kepl E, Sydeman C, Brunette N, Murphy M, Fiala B, Carter L, White AG, Trisal M, Hsieh CL, Russell-Lodrigue K, Monjure C, Dufour J, Spencer S, Doyle-Meyers L, Bohm RP, Maness NJ, Roy C, Plante JA, Plante KS, Zhu A, Gorman MJ, Shin S, Shen X, Fontenot J, Gupta S, O'Hagan DT, Van Der Most R, Rappuoli R, Coffman RL, Novack D, McLellan JS, Subramaniam S, Montefiori D, Boyd SD, Flynn JL, Alter G, Villinger F, Kleanthous H, Rappaport J, Suthar MS, King NP, Veesler D, Pulendran B. Arunachalam PS, et al. Among authors: rappuoli r. Nature. 2021 Jun;594(7862):253-258. doi: 10.1038/s41586-021-03530-2. Epub 2021 Apr 19. Nature. 2021. PMID: 33873199
Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
Ryan EJ, McNeela E, Murphy GA, Stewart H, O'hagan D, Pizza M, Rappuoli R, Mills KH. Ryan EJ, et al. Among authors: rappuoli r. Infect Immun. 1999 Dec;67(12):6270-80. doi: 10.1128/IAI.67.12.6270-6280.1999. Infect Immun. 1999. PMID: 10569737 Free PMC article.
The safety of vaccines.
O'Hagan DT, Rappuoli R. O'Hagan DT, et al. Among authors: rappuoli r. Drug Discov Today. 2004 Oct 1;9(19):846-54. doi: 10.1016/S1359-6446(04)03234-9. Drug Discov Today. 2004. PMID: 15381137 Free PMC article. Review.
Novel approaches to vaccine delivery.
O'Hagan DT, Rappuoli R. O'Hagan DT, et al. Among authors: rappuoli r. Pharm Res. 2004 Sep;21(9):1519-30. doi: 10.1023/b:pham.0000041443.17935.33. Pharm Res. 2004. PMID: 15497674 Free PMC article. Review.
Novel approaches to pediatric vaccine delivery.
O'Hagan DT, Rappuoli R. O'Hagan DT, et al. Among authors: rappuoli r. Adv Drug Deliv Rev. 2006 Apr 20;58(1):29-51. doi: 10.1016/j.addr.2005.12.002. Epub 2006 Feb 9. Adv Drug Deliv Rev. 2006. PMID: 16480788 Review.
Molecular and cellular signatures of human vaccine adjuvants.
Mosca F, Tritto E, Muzzi A, Monaci E, Bagnoli F, Iavarone C, O'Hagan D, Rappuoli R, De Gregorio E. Mosca F, et al. Among authors: rappuoli r. Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10501-6. doi: 10.1073/pnas.0804699105. Epub 2008 Jul 23. Proc Natl Acad Sci U S A. 2008. PMID: 18650390 Free PMC article.
804 results